Dow Down 0.18% Nasdaq Down 0.33%

Achillion Pharmaceuticals, Inc. (ACHN)

-NasdaqGS
11.71 0.23(1.93%) Oct 29, 4:00PM EDT
Prev Close:11.94
Open:11.80
Bid:11.49 x 1000
Ask:11.62 x 100
1y Target Est:13.67
Beta:2.34
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:11.51 - 11.93
52wk Range:2.26 - 13.80
Volume:3,008,736
Avg Vol (3m):6,177,680
Market Cap:1.15B
P/E (ttm):N/A
EPS (ttm):-0.61
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ACHNDown 1.93%1.15B
GSK108.37B
JNJ297.71B
RHHBY249.58B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.68
Quarterly EPS Est (Sep-14) :-0.18
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-3.17

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Achillion Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes anti-infective drug therapies in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback